Association Between Systemic and Pulmonary Vascular Dysfunction in COPD

References

• ChenW, ThomasJ, SadatsafaviM, FitzGeraldJM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-626208998
   PubMed Web of Science ®Google Scholar
• McGarveyLP, JohnM, AndersonJA, ZvarichM, WiseRA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):411–415.17311843
   PubMed Web of Science ®Google Scholar
• BarrRG, Mesia-VelaS, AustinJH, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) study. Am J Respir Crit Care Med. 2007;176(12):1200–1207. doi:10.1164/rccm.200707-980OC17761614
   PubMed Web of Science ®Google Scholar
• ChandraD, GuptaA, StrolloPJ Jr, et al. Airflow limitation and endothelial dysfunction: unrelated and independent predictors of atherosclerosis. Am J Respir Crit Care Med. 2016;194(1):38–47. doi:10.1164/rccm.201510-2093OC26771278
   PubMed Web of Science ®Google Scholar
• García-LucioJ, PeinadoVI, de JoverL, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One. 2018;13(4):e0195724. doi:10.1371/journal.pone.019572429672621
   PubMed Web of Science ®Google Scholar
• Houben-WilkeS, JörresRA, BalsR, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences–comorbidities network study. Am J Respir Crit Care Med. 2017;195(2):189–197. doi:10.1164/rccm.201602-0354OC27532739
   PubMed Web of Science ®Google Scholar
• CelermajerDS, SorensenKE, GoochVM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111–1115. doi:10.1016/0140-6736(92)93147-F1359209
   PubMed Web of Science ®Google Scholar
• MillsNL, MillerJJ, AnandA, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63(4):306–311. doi:10.1136/thx.2007.08349318024535
   PubMed Web of Science ®Google Scholar
• MaclayJD, McAllisterDA, MillsNL, et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(6):513–520. doi:10.1164/rccm.200903-0414OC19542477
   PubMed Web of Science ®Google Scholar
• McAllisterDA, MaclayJD, MillsNL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1208–1214. doi:10.1164/rccm.200707-1080OC17885263
   PubMed Web of Science ®Google Scholar
• PetrosilloN. Pulmonary vascular disease and infection: a tale of two diseases. Clin Microbiol Infect. 2011;17(1):5–6. doi:10.1111/j.1469-0691.2010.03291.x20545957
   PubMed Web of Science ®Google Scholar
• GalièN, HumbertM, VachieryJL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–975. doi:10.1183/13993003.01032-201526318161
   PubMed Web of Science ®Google Scholar
• PortilloK, TorralbaY, BlancoI, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;14(10):1313–1320. doi:10.2147/COPD.S78180
   Web of Science ®Google Scholar
• AndersenKH, IversenM, KjaergaardJ, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31(4):373–380. doi:10.1016/j.healun.2011.11.02022226804
   PubMed Web of Science ®Google Scholar
• KesslerR, FallerM, FourgautG, MennecierB, WeitzenblumE. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158–164. doi:10.1164/ajrccm.159.1.98031179872834
   PubMed Web of Science ®Google Scholar
• WellsJM, WashkoGR, HanMK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367(10):913–921. doi:10.1056/NEJMoa120383022938715
   PubMed Web of Science ®Google Scholar
• PizarroS, García-LucioJ, PeinadoVI, et al. Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e106163. doi:10.1371/journal.pone.010616325171153
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. [homepage on the Internet]. Available from: https://goldcopd.org/gold-reports. Accessed 621, 2020..
   Google Scholar
• LaurentS, CockcroftJ, Van BortelL, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605. doi:10.1093/eurheartj/ehl25417000623
   PubMed Web of Science ®Google Scholar
• ButlinM, QasemA. Large artery stiffness assessment using sphygmocor technology. Pulse (Basel). 2017;4(4):180–192. doi:10.1159/00045244828229053
   PubMedGoogle Scholar
• WilkinsonIB, MacCallumH, FlintL, CockcroftJR, NewbyDE, WebbDJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(Pt 1):263–270. doi:10.1111/j.1469-7793.2000.t01-1-00263.x10811742
   PubMed Web of Science ®Google Scholar
• HarveyRE, BarnesJN, HartEC, NicholsonWT, JoynerMJ, CaseyDP. Influence of sympathetic nerve activity on aortic hemodynamics and pulse wave velocity in women. Am J Physiol Heart Circ Physiol. 2017;312(2):H340‐H346. doi:10.1152/ajpheart.00447.2016
   PubMed Web of Science ®Google Scholar
• ThijssenDH, BlackMA, PykeKE, et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300(1):H2–12. doi:10.1152/ajpheart.00471.201020952670
   PubMed Web of Science ®Google Scholar
• CorrettiMC, AndersonTJ, BenjaminEJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265. doi:10.1016/S0735-1097(01)01746-611788217
   PubMed Web of Science ®Google Scholar
• LiuCY, ParikhM, BluemkeDA, et al. Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study. J Magn Reson Imaging. 2018;47(1):262–271. doi:10.1002/jmri.2575328488348
   PubMed Web of Science ®Google Scholar
• VaesAW, SpruitMA, TheunisJ, et al. Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation. Expert Rev Respir Med. 2017;11(12):1021–1031. doi:10.1080/17476348.2017.138927728978239
   PubMed Web of Science ®Google Scholar
• CsomaB, BikovA, NagyL, et al. Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD. Respir Res. 2019;20(1):156. doi:10.1186/s12931-019-1133-831311549
   PubMed Web of Science ®Google Scholar
• CelermajerDS, SorensenKE, GeorgakopoulosD, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149–2155. doi:10.1161/01.CIR.88.5.21498222109
   PubMed Web of Science ®Google Scholar
• PeinadoVI, BarberaJA, RamirezJ, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274(6):L908–13. doi:10.1152/ajplung.1998.274.6.L9089609729
   PubMed Web of Science ®Google Scholar
• DomingoE, GrignolaJC, AguilarR, MesseguerML, RomanA. Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation. Respir Res. 2017;18(1):85. doi:10.1186/s12931-017-0568-z28477618
   PubMed Web of Science ®Google Scholar
• Agoston-ColdeaL, LupuS, MocanT. Pulmonary artery stiffness by cardiac magnetic resonance imaging predicts major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. Sci Rep. 2018;8(1):14447. doi:10.1038/s41598-018-32784-630262820
   PubMed Web of Science ®Google Scholar
• FarreroM, BlancoI, BatlleM, et al. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction. Circ Heart Fail. 2014;7(5):791–798. doi:10.1161/CIRCHEARTFAILURE.113.00094225047042
   PubMed Web of Science ®Google Scholar
• WrightJL, TaiH, WangR, WangX, ChurgA. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol. 2007;292(1):L125–33. doi:10.1152/ajplung.00539.200516905636
   PubMed Web of Science ®Google Scholar
• HoffmannJ, WilhelmJ, MarshLM, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med. 2014;190(1):98–111. doi:10.1164/rccm.201401-0037OC24918967
   PubMed Web of Science ®Google Scholar
• Karmouty-QuintanaH, WengT, Garcia-MoralesLJ, et al. Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49(6):1038–1047. doi:10.1165/rcmb.2013-0089OC23855769
   PubMed Web of Science ®Google Scholar
• LlinàsL, PeinadoVI, Ramon GoñiJ, et al. Similar gene expression profiles in smokers and patients with moderate COPD. Pulm Pharmacol Ther. 2011;24(1):32–41. doi:10.1016/j.pupt.2010.10.01020970515
   PubMed Web of Science ®Google Scholar
• SeravalleG, ManciaG, GrassiG. Sympathetic nervous system, sleep, and hypertension. Curr Hypertens Rep. 2018;20(9):74. doi:10.1007/s11906-018-0874-y29980938
   PubMed Web of Science ®Google Scholar
• PhillipsDB, SteinbackCD, CollinsSÉ, et al. The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease. J Physiol. 2018;596(15):3233‐3244. doi:10.1113/JP275762
   Web of Science ®Google Scholar
• EaganTML, UelandT, WagnerPD, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35(3):540–548. doi:10.1183/09031936.0008820919643942
   PubMed Web of Science ®Google Scholar
• SafranowK, DziedziejkoV, RzeuskiR, et al. Plasma concentrations of TNF-α and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Tissue Antigens. 2009;74(5):386–392. doi:10.1111/j.1399-0039.2009.01332.x19845893
   PubMedGoogle Scholar
• JoppaP, PetrasovaD, StancakB, TkacovaR. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 2006;130(2):326–333. doi:10.1378/chest.130.2.32616899829
   PubMed Web of Science ®Google Scholar
• VrizO, MotojiY, FerraraF, BossoneE, NaeijeR. The right heart-pulmonary circulation unit in systemic hypertension. Heart Fail Clin. 2018;14(3):247–253. doi:10.1016/j.hfc.2018.02.00229966624
   PubMed Web of Science ®Google Scholar
• ZuoL, RoseBA, RobertsWJ, HeF, Banes-BerceliAK. Molecular characterization of reactive oxygen species in systemic and pulmonary hypertension. Am J Hypertens. 2014;27(5):643–650. doi:10.1093/ajh/hpt29224552887
   PubMed Web of Science ®Google Scholar
• LeggioM, FuscoA, LimongelliG, SgorbiniL. Exercise training in patients with pulmonary and systemic hypertension: a unique therapy for two different diseases. Eur J Intern Med. 2018;47:17–24. doi:10.1016/j.ejim.2017.09.01028911936
   PubMed Web of Science ®Google Scholar
• WoutersEFM, FranssenFM. Chronic obstructive pulmonary disease: shifting the paradigm to the vasculature. Am J Respir Crit Care Med. 2019;199(3):258–259. doi:10.1164/rccm.201808-1542ED30265129
   PubMed Web of Science ®Google Scholar
• OelsnerEC, BaltePP, GramsME, et al. Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease. The NHLBI pooled cohorts study. Am J Respir Crit Care Med. 2019;199(3):321–332. doi:10.1164/rccm.201803-0402OC30261735
   PubMed Web of Science ®Google Scholar
• NathanSD, BarberàJA, GaineSP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;53(1):1801914. doi:10.1183/13993003.01914-201830545980
   PubMed Web of Science ®Google Scholar
• SimonneauG, MontaniD, CelermajerDS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi:10.1183/13993003.01913-201830545968
   PubMed Web of Science ®Google Scholar
• VachiéryJL, TedfordRJ, RosenkranzS, et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019;53(1):1801897. doi:10.1183/13993003.01897-201830545974
   PubMed Web of Science ®Google Scholar